Home > Quotes > PBE

PowerShares Dynamic Biotech &Genome Stock Quote & Summary Data

(ETF)
PBE 
$29.75
*  
0.30
  negative  
1.02%
Get PBE Alerts
*Delayed - data as of May 21, 2013 


Community Rating:
View:    PBE After Hours
 
 

Symbol List Views

ETF Details

CHARTS

ETF NEWS

FUNDAMENTALS

 Save stocks for next time
 | Sponsored

 Intraday Chart

5d | 1m | 6m | 12m | More Charting



Description:The PowerShares Dynamic Biotechnology & Genome Portfolio seeks investment results that correspond generally to the price and yield (before the Fund's fees and expenses) of an equity index called the Dynamic Biotechnology & Genome Intellidex Index (the "Underlying Intellidex"). The Underlying Intellidex is comprised of stocks of 30 U.S. biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research. These companies may include, for example, companies involved in the research, development or production of pharmaceuticals, including veterinary drugs. Stocks are selected principally on the basis of their capital appreciation potential as identified by NYSE Arca pursuant to a proprietary Intellidex methodology. The Fund will normally invest at least 80% of its total assets in common stocks of biotechnology companies and genome companies.

Underlying Index Dynamic Biotechnology & Genome Intellidex Index
Management Fee 0.63
Asset Class Equity
Leverage 1


News Headlines for PBE

Top Holdings
AMGN Amgen Inc. 5.74%
BMRN Biomarin Pharmaceutical Inc. 5.29%
REGN Regeneron Pharmaceuticals 5.69%
ALXN Alexion Pharmaceuticals 5.06%
BIIB Biogen Idec Inc 5.61%
GILD Gilead Sciences 5.43%
LIFE Life Technologies Corp. 5.43%
ILMN Illumina 4.46%
WAT Waters Corp. 4.8%
PCYC Pharmacyclics 3.97%
ONXX Onyx Pharmaceuticals 4.2%
NPSP Nps Pharmaceuticals 3.89%
ISIS Isis Pharmaceuticals 3.19%
INCY Incyte Corp. 3.12%
OPTR Optimer Pharmaceuticals 3.46%
VRTX Vertex Pharmaceuticals Inc. 3.55%
THRX Theravance 3.46%
MNTA Momenta Pharmaceuticals 3.05%
KERX Keryx Biopharmaceuticals 3.15%
CBST Cubist Pharmaceuticals 2.97%